2 results
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
The Board has established three standing committees: an Audit Committee, a Compensation Committee and a Governance Committee. Members serve on these committees until their resignation or until otherwise determined by our Board. Our Board may establish other committees as it deems necessary or appropriate from time to time, for example it has established a Transaction Committee. Copies of the written charters of each standing committee are available in the "Corporate Governance" section of our investor relations website at https://investors.acelyrin.com. The following table provides membership and meeting information for the year ended December 31, 2023 for each of these standing committees:
Name | Audit(1) | Compensation(1) | Nominating and Corporate Governance(1) | |||||||||||||||||
Bruce C. Cozadd | X | |||||||||||||||||||
Dan Becker, M.D., Ph.D. | X | |||||||||||||||||||
Alan Colowick, M.D., M.P.H. | X | |||||||||||||||||||
Henry O. Gosebruch | X | |||||||||||||||||||
Shao-Lee Lin, M.D., Ph.D. | ||||||||||||||||||||
Patrick Machado, J.D. | X* | X | ||||||||||||||||||
Beth Seidenberg, M.D. | ||||||||||||||||||||
Dawn Svoronos | X | X* | ||||||||||||||||||
Lynn Tetrault, J.D. | X* | |||||||||||||||||||
Total meetings in fiscal year 2023 | 6 | 7 | 3 |
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
The following table represents aggregate fees billed to us for the fiscal years ended December 31, 2023 and December 31, 2022, by PricewaterhouseCoopers LLP, our principal accountant.
Fiscal Year Ended | |||||||||||
2023 | 2022 | ||||||||||
(in thousands) | |||||||||||
Audit Fees(1) | $ | 3,530 | $ | 1,219 | |||||||
Audit-related Fees | $ | — | $ | — | |||||||
Tax Fees | $ | — | $ | — | |||||||
All Other Fees(2) | $ | 2 | $ | — | |||||||
Total Fees | $ | 3,532 | $ | 1,219 |
- Prev
- 1
- Next